-
Hemophilia Treatment Market is Unearthed through Growing Number of R & D Projects in Sector
Oct 27, 2016, 08:40 AM by Michael CroftALBANY, NY, UNITED STATES - Oct 27, 2016 - The research report on the global hemophilia treatment market provides every detail that is critical in understanding the nature of the changing market dynamicsFull story -
Creative Biolabs Announces a Satisfactory Result in Its Research Cooperation with In-Cell-Art
Oct 26, 2016, 22:18 PM by Michael CroftSHIRLEY, NY, USA - Oct 27, 2016 - Creative Biolabs, a biotech company specialized in providing custom biotechnology and pharmaceutical services that cover the full scope of biotechnology needs, announces that its services provided to In-Cell-Art (ICA) lead to a satisfactory result in the research collaboration between ICA and VirbacFull story -
Lab7 Systems Secures $3.0M Financing to Fuel Platform Growth and Commercial Expansion
Oct 26, 2016, 14:31 PM by Michael CroftAUSTIN, TX - Oct 26, 2016 - Lab7 Systems, Inc., a leader in workflow management for data-intensive life science applications, announced today the closing of $3Full story -
China National GeneBank Opening Hopes To Provide Resource For Global Health
Oct 26, 2016, 10:20 AM by Michael CroftFull storyBio-IT World Brief | The official opening of the China National GeneBank (CNGB) marks a new phase in Chinese-International genomics collaboration, providing scientists from across the world with access to one of the world's most comprehensive and sophisticated biorepositories with the goal of enabling breakthroughs in human health research, and contributing to global biodiversity conservation efforts.
-
Digital Health Market: Converging Digital and Genomic Revolutions with Health and Society
Oct 26, 2016, 03:52 AM by Michael CroftALBANY, NY, UNITED STATES - Oct 26, 2016 - Digital health is technology-enabled care that involves the convergence of digital media, health technology, and mobile devicesFull story -
Solving The Lack Of Diversity In Genomic Research
Oct 25, 2016, 16:55 PM by Michael CroftMIT Technology Review | An overwhelming majority of the data collected is from people of European ancestry. But researchers are trying to change that.Full story -
Industry and Government Bodies Gather for Crucial Updates into Antibiotic Resistance in Just 3 Weeks at Superbugs USA 2016
Oct 25, 2016, 15:56 PM by Michael CroftISELIN, NJ, UNITED KINGDOM - Oct 26, 2016 - Just 3 weeks remain until SMi Group open its doors to host Superbugs & Superdrugs USA, the American instalment of its long running European conferenceFull story -
Chinese Firm Admits Its Hacked Products Were Behind Friday's DDOS Attack
Oct 25, 2016, 09:06 AM by Michael CroftComputerworld | A Chinese electronics component manufacturer says its products inadvertently played a role in a massive cyberattack that disrupted major internet sites in the U.S. on Friday.Full story -
Antibody Drug Conjugates Market Driven by Extensive Research and Development Activities
Oct 25, 2016, 06:59 AM by Michael CroftALBANY, NY, UNITED STATES - Oct 25, 2016 - Antibody drug conjugates are monoclonal antibodies that are attached with biologically active drugsFull story -
Pneumonia Diagnostics & Technologies Market – Evaluating New Diagnostic Technologies
Oct 25, 2016, 03:55 AM by Michael CroftALBANY, NY, UNITED STATES - Oct 25, 2016 - Pneumonia is a type of lung infection caused by microorganisms such as bacteria, virus, fungi and parasitesFull story -
UgenTec reaches milestone; acquires ISO 13485 certificate & CE-IVD label for artificially intelligent PCR interpretation software
Oct 25, 2016, 03:39 AM by Michael CroftHASSELT, BELGIË - Oct 25, 2016 - UgenTec, the Belgian bioinformatics company that is developing universal & intelligent PCR analysis software, has received its ISO 13485 certificationFull story -
Creative Bioarray Enlarged Its Primary Cells Variety
Oct 25, 2016, 00:21 AM by Michael CroftLONG ISLAND CITY, NY, UNITED STATES - Oct 24, 2016 - After transferred its core products line into cells, Creative Bioarray is endeavoring to enlarge its cells products variety to become a one-stop cells and related kits or tools supplier in USA, which doesnt mean the company sold a narrow range of cells before the strategy launchFull story -
Benchling Announces $7M in New Funding Led by Thrive Capital
Oct 24, 2016, 13:04 PM by Michael CroftSAN FRANCISCO, CA, UNITED STATES - Oct 24, 2016 - Benchling, the next-generation life science R&D software company, announced that is has raised $7 million in new fundingFull story -
Research at MDI Biological Laboratory Examines Role of Early-Life Stress in Adult Illness
Oct 24, 2016, 12:47 PM by Michael CroftBAR HARBOR, ME - Oct 24, 2016 - Scientists have long known that chronic exposure to psychosocial stress early in life can lead to an increased vulnerability later in life to diseases linked to immune dysfunction and chronic inflammation, including arthritis, asthma, cancer, diabetes, heart disease and even mental illnessFull story -
The Trials of Juno
Oct 24, 2016, 09:28 AM by Michael CroftThe Economist | Juno Therapeutics, a young biotech firm focused on cancer, promises both risk and reward with its attempt to master the T-cell. The firm is on the forefront of the most promising area of cancer treatments in decades.Full story -
Cenduit Participates in QuintilesIMS Webinar to Share Tips on Continuous Glucose Monitoring (CGM) in Clinical Trials
Oct 24, 2016, 09:07 AM by Michael CroftRESEARCH TRIANGLE PARK, NC, UNITED STATES - Oct 24, 2016 - Cenduit, a joint venture between QuintilesIMS and Thermo Fisher Scientific, is participating in a free webinar hosted by QuintilesIMS, where expert guest speakers will highlight regulatory trends, technology innovation and industry perspectives surrounding Continuous Glucose Monitoring (CGM) to help sponsors develop smarter diabetes clinical trialsFull story -
New Advance in Peptides Has Raised Increasing Attention
Oct 24, 2016, 02:46 AM by Michael CroftSHIRLEY, NY - Oct 24, 2016 - As is known, it has long been a dream in medicine and pharmacy to use peptides as drugs. The driving force for such application is based on the ability of these compounds to improve the antibodies in the bodyFull story -
Welcome to DNA.Land: Trait Prediction, A Breast Cancer Research Collaboration, And a Facebook Group
Oct 21, 2016, 09:50 AM by Michael CroftFull storyBio-IT World “We’ve already entered the era of ubiquitous genetic information.” says Yaniv Erlich, so he and colleagues have built DNA.Land, to crowdsource these available genomes from individuals. A ticker on the DNA.Land website counts almost 32,000 genomes deposited into DNA.Land so far. The project recently launched a collaboration with the National Breast Cancer Coalition and has started offering trait predictions.
-
Hydrolases Products Line Has Been Updated By Scientists in Creative Enzymes
Oct 20, 2016, 23:44 PM by Michael CroftSHIRLEY, NY - Oct 21, 2016 - October 20, 2016, experienced scientists in Creative Enzymes introduced a part of newly-updated products belonging to hydrolases products, which symbolized the beginning of developing hydrolases products in Creative EnzymesFull story -
Illumina Builds Africa GWAS Chip With H3Africa Initiative
Oct 20, 2016, 13:45 PM by Michael CroftBio-IT World | Last week, Illumina announced that it is creating an array for genome-wide association studies (GWAS) by the Human Heredity and Health in Africa (H3Africa) Initiative. The array—which isn’t available yet—will be include 2.5 million variations of specific interest to African populations.Full story